FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/05/2026
Back to search
Official data from USPTO
S SEAMLESS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
08/05/2026
Trademark type
Combined
Nice classes
1, 5, 42
Filing date
12/14/2023
Registration date
05/05/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/05/2026
Last transaction
08/05/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
27
Owner location
DE
Examiner
MESSICK, TABITHA LEE
Law office
L40
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the wording "SEAMLESS" in stylized font in gradient from blue to green next to the letter "S" comprised of curved bands in green and blue.
Holders and representatives
Holders
Seamless Therapeutics GmbH
Representatives
Brian J. Focarino COOLEY LLP
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals for use in industry and science; biological preparations for use in industry and sciencebiological reagentsfor use in industry and sciencenot for medical purposes
Class 5
Pharmaceutical and biological preparations for gene therapies and gene-editing therapiesall for the treatment of genetic and viral diseases; medicalpharmaceutical and biopharmaceutical preparations and substances containing programmable recombinases for the treatment of genetic and viral diseases; pharmaceutical goods and preparationsgene transferregulationmodulation and delivery medications for the treatment of genetic and viral diseases and disorders; productsagentsfor medical purposesfor veterinary purposes in the nature of pharmaceutical preparations for cellulargenome and gene editing therapies to treat geneticoncologicalimmune system-relatedinflammatory disorders and diseases; genome editable enzymes being enzymes for medical purposes; DNA recombinant enzymes being enzymes for medical purposes; DNA editable enzymesespeciallyrecombinases and integrases being enzymes for medical purposes; genome editable enzymes for the treatment of diseases being enzymes for medical purposes; DNA recombinant enzymes for the treatment of diseases being enzymes for medical purposes; DNA editable enzymesin particular recombinases and integrasesfor the treatment of diseases being enzymes for medical purposes
Class 42
Scientific and technological servicesproduct research and testing of pharmaceuticals for cell and gene therapies in the field of pharmaceutical product development for the creation of bioinformatic algorithms and models; development of pharmaceutical preparations and medicinesnone of the foregoing for diagnostics; pharmaceutical product developmentnone of the foregoing for diagnostics; pharmaceutical products development of genome editable enzymes for treatment and not diagnostic purposes; pharmaceutical products development of DNA editable enzymesin particular recombinases and integrasesfor treatment and not diagnostic purposes
Publications
History of USPTO decisions and trademark events.
40 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/25/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/05/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
05/05/2026
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
04/16/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/30/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
03/29/2026
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/19/2026
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
03/19/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/19/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/19/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/17/2026
PUBO
PUBLISHED FOR OPPOSITION
03/17/2026
GPNX
NOTIFICATION PROCESSED BY IB
03/12/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/11/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/25/2026
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/24/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/18/2026
XAEC
EXAMINER'S AMENDMENT ENTERED
02/18/2026
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/18/2026
GNEA
EXAMINERS AMENDMENT E-MAILED
02/18/2026
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/18/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/13/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/13/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/13/2026
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/15/2025
GNRT
NON-FINAL ACTION E-MAILED
07/15/2025
CNRT
NON-FINAL ACTION WRITTEN
07/15/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/21/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/21/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/21/2025
RFNT
REFUSAL PROCESSED BY IB
12/14/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/22/2024
RFRR
REFUSAL PROCESSED BY MPU
11/22/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/15/2024
CNRT
NON-FINAL ACTION WRITTEN
11/14/2024
DOCK
ASSIGNED TO EXAMINER
11/05/2024
MAFR
APPLICATION FILING RECEIPT MAILED
11/04/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/04/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/31/2024
Continuous trademark protection
Get notified about every new filing that threatens S SEAMLESS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.